Pacer Advisors
HOLX

Pacer Advisors’s Hologic HOLX Stock Holding History

Pacer Advisors’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,131
Closed -$841K – 2590
2026
Q1 		$841K Sell
11,131
-6,377
-36% -$479K ﹤0.01% 1285
2025
Q4 		$1.3M Sell
17,508
-2,009
-10% -$147K ﹤0.01% 1313
2025
Q3 		$1.32M Sell
19,517
-1,222,312
-98% -$81.1M ﹤0.01% 1287
2025
Q2 		$80.9M Sell
1,241,829
-199,792
-14% -$12M 0.2% 107
2025
Q1 		$89M Sell
1,441,621
-2,223,077
-61% -$147M 0.21% 98
2024
Q4 		$264M Buy
3,664,698
+3,572,585
+3,878% +$279M 0.57% 42
2024
Q3 		$7.5M Buy
92,113
+25,318
+38% +$2.03M 0.02% 527
2024
Q2 		$4.96M Buy
66,795
+13,387
+25% +$1M 0.01% 587
2024
Q1 		$4.16M Buy
53,408
+33,412
+167% +$2.49M 0.01% 624
2023
Q4 		$1.43M Sell
19,996
-1,397
-7% -$97.3K ﹤0.01% 938
2023
Q3 		$1.48M Sell
21,393
-142
-0.7% -$10.7K 0.01% 679
2023
Q2 		$1.74M Sell
21,535
-1,346,239
-98% -$110M 0.01% 786
2023
Q1 		$110M Sell
1,367,774
-27,883
-2% -$2.24M 0.47% 56
2022
Q4 		$104M Buy
1,395,657
+413,331
+42% +$29.4M 0.53% 50
2022
Q3 		$63.4M Sell
982,326
-256,612
-21% -$17.8M 0.44% 55
2022
Q2 		$85.9M Buy
1,238,938
+660,229
+114% +$49M 0.64% 40
2022
Q1 		$44.5M Buy
578,709
+379,749
+191% +$27.3M 0.36% 63
2021
Q4 		$15.2M Buy
198,960
+44,024
+28% +$3.24M 0.16% 107
2021
Q3 		$11.4M Buy
154,936
+28,856
+23% +$2.16M 0.14% 176
2021
Q2 		$8.41M Buy
126,080
+111,949
+792% +$7.48M 0.12% 197
2021
Q1 		$1.05M Sell
14,131
-2,626
-16% -$199K 0.02% 753
2020
Q4 		$1.22M Sell
16,757
-10,022
-37% -$707K 0.02% 616
2020
Q3 		$1.78M Sell
26,779
-5,473
-17% -$346K 0.04% 458
2020
Q2 		$1.84M Buy
+32,252
New +$1.58M 0.04% 396
2020
Q1 		– Sell
-30,350
Closed -$1.58M – 871
2019
Q4 		$1.58M Sell
30,350
-3,597
-11% -$179K 0.07% 366
2019
Q3 		$1.71M Buy
33,947
+4,113
+14% +$202K 0.04% 568
2019
Q2 		$1.43M Buy
29,834
+5,729
+24% +$265K 0.04% 654
2019
Q1 		$1.17M Buy
+24,105
New +$1.09M 0.03% 417
2018
Q4 		– Sell
-25,489
Closed -$1.04M – 763
2018
Q3 		$1.04M Buy
25,489
+3,893
+18% +$157K 0.04% 635
2018
Q2 		$859K Buy
21,596
+3,761
+21% +$145K 0.04% 701
2018
Q1 		$666K Buy
17,835
+3,021
+20% +$122K 0.04% 639
2017
Q4 		$633K Buy
14,814
+5,198
+54% +$207K 0.04% 621
2017
Q3 		$353K Buy
9,616
+1,203
+14% +$48.6K 0.03% 811
2017
Q2 		$382K Buy
8,413
+279
+3% +$12.3K 0.04% 749
2017
Q1 		$346K Buy
8,134
+337
+4% +$13.7K 0.04% 701
2016
Q4 		$312K Buy
7,797
+2,798
+56% +$108K 0.04% 666
2016
Q3 		$194K Sell
4,999
-30
-0.6% -$1.13K 0.03% 831
2016
Q2 		$174K Buy
5,029
+953
+23% +$33K 0.03% 860
2016
Q1 		$141K Buy
4,076
+563
+16% +$19.6K 0.03% 498
2015
Q4 		$136K Buy
+3,513
New +$137K 0.03% 484

Other funds holding HOLX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Pacer Advisors's HOLX Position: Q2 2026 in Review

Pacer Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 11,131 shares — an estimated $841K sold.

Pacer Advisors first reported a position in HOLX in Q4 2015 and held it in 40 quarters. The position peaked at $264M in Q4 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Pacer Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Pacer Advisors sold 11,131 Hologic shares in Q2 2026, an estimated $841K.
  • Pacer Advisors first reported a position in Hologic in Q4 2015 and held it in 40 quarters.
  • Pacer Advisors's Hologic position peaked at $264M in Q4 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.